USBC

USBC · NYSE American

$0.46+$0.022 (+5.02%)TodayMarket closed ·
Prev close $0.438

About USBC

USBC, Inc. engages in the development, marketing, and sale of a photonics technology. The company is headquartered in Reno, Nevada and currently employs 16 full-time employees. The company went IPO on 2006-04-12. The firm is focused on the development of the USBC tokenized deposit offering, a United States dollar denominated tokenized deposit that operates on blockchain technology and is embedded with digital identity. USBC is a tokenized representation of a bank deposit offered by banking institutions to their customers. The firm has identified numerous impactful use cases for USBC including financial inclusion and open access, cross-border payments and remittances, hedge against local currency instability, 24/7 instant payments, integrated programmable payments, and treasury management. The firm's platform is being designed to serve a broad group of customers in the emerging blockchain-based banking ecosystem, including retail users, fintech partners, and institutional counterparties.

Employees
18
Headquarters
Reno, Nevada
Listed
Apr 12, 2006
Sector
Health Care
Industry
Health Care Equipment & Supplies

USBC key statistics

Market cap
181.19M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
283.94K
Volume
89.02K
Open price
$0.4505
High today
$0.4746
Low today
$0.438
52 Week high
$1.29
52 Week low
$0.2853

USBC (USBC) at a glance

USBC (USBC) last traded at $0.46, with a market cap of 181.19M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.438 and $0.4746. The current price is 5.0% above the day's low and 3.1% below its high.

Volume so far is 89.02K shares, below the average of 283.94K shares a day.

Over the past year USBC has ranged from $0.2853 to $1.29, and now sits 17% of the way up that range.

USBC met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q1 FY25 it reported -$2.00 per share against an estimate of -$2.04.

USBC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 13.9% on average.

  1. Q4 FY22: reported -$5.00 per share against an estimate of $0.00
  2. Q3 FY23: reported -$7.20 per share against an estimate of -$1.22
  3. Q4 FY23: reported -$2.40 per share against an estimate of $1.22
  4. Q2 FY24: reported -$2.80 per share against an estimate of -$2.04
  5. Q1 FY24: reported -$0.04 per share against an estimate of $0.00
  6. Q3 FY24: reported -$2.00 per share against an estimate of -$2.45
  7. Q4 FY24: reported -$1.60 per share against an estimate of -$2.04
  8. Q1 FY25: reported -$2.00 per share against an estimate of -$2.04

USBC news

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • 12 Health Care Stocks Moving In Monday's Intraday Session

  • Press releaseGlobe Newswire

    USBC Announces Completion of Corporate Name and Ticker Change Following Strategic Acquisition

  • Press releaseACCESS Newswire

    CORRECTION: Greg Kidd & Know Labs Announce Closing of $125M Strategic Acquisition

  • Press releaseACCESS Newswire

    Greg Kidd & Know Labs Announce Closing of [$100]M Strategic Acquisition

Similar companies

Companies in the same industry as USBC

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.